Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 30,000 shares at $88.28 ($2.7M) on 2024-02-09, disclosed to the SEC on 2024-02-12.
Scheduled sale ($2.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.77 | 15,000 | $1.3M | 50.4% |
| 2 | $88.28 | 15,000 | $1.3M | 49.6% |
| Total | $89.03 avg | 30,000 | $2.7M | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |